Fierce Biotech Week Panel: Asia’s Outsized Role in U.S. Pharma: Structuring Cross-Border Deals Amid Capital Controls, IP, and Antitrust Scrutiny
Freshfields’ partner Kristen Riemenschneider will be presenting at the upcoming Fierce Biotech Week.
She will speak on a panel titled “Asia’s Outsized Role in U.S. Pharma: Structuring Cross-Border Deals Amid Capital Controls, IP, and Antitrust Scrutiny”. The panel will discuss, among other things, how Asian capital, biopharma innovation, and government priorities are reshaping U.S. licensing, partnerships, and M&A activity.
Freshfields is a proud partner of Fierce Biotech Week, a Boston conference that brings together leaders from biotech, pharma and the investment community.
